Akineton 2 mg Tablets Blister Pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

biperiden hydrochloride

Disponibbli minn:

Amdipharm Mercury Australia Pty Ltd

Klassi:

Medicine Registered

L-istatus ta 'awtorizzazzjoni:

Registered

Fuljett ta 'informazzjoni

AKINETON
®
_biperiden hydrochloride_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Akineton.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking Akineton
against the benefits they expect it
will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
TAKING THIS MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT AKINETON IS USED
FOR
Akineton is used to treat symptoms
of parkinsonism.
The symptoms of parkinsonism
include slow and unsteady
movement, muscle stiffness and
shaking (tremors). If untreated
parkinsonism can cause difficulty in
performing normal daily activities.
Symptoms of parkinsonism can be
caused by certain diseases of the
brain affecting movement, such as
Parkinson's disease. They can also be
caused by some medicines that are
used to treat certain mental
conditions.
It is believed the symptoms of
parkinsonism are caused by a lack of
dopamine, a naturally occurring
chemical produced by certain brain
cells. When not enough dopamine is
present, acetylcholine which is
another naturally occurring chemical
produced by brain cells, can interfere
with the regions of the brain that
control muscle movement.
Akineton blocks the effects of
acetylcholine. In many patients, this
reduces the symptoms of shaking and
muscle stiffness.
Akineton is also used to treat cramps
that occur during the night.
Akineton belongs to a group of
medicines called anticholinergics. It
is available as tablets.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY AKINETON
HAS BEEN PRESCRIBED FOR YOU.
Your doctor may have prescribed
Akineton for another reason.
This medicine is available only with
a doctor’s prescription.
BEFORE YOU TAKE
AKINETON
_WHEN YOU MUST NOT TAKE IT_
DO NOT TAKE AKINETON IF YOU HAVE
AN ALLERGY TO:
•
any medicine containing
biperiden
•
any of the in

Karatteristiċi tal-prodott

Page 1 of 6
PRODUCT INFORMATION
AKINETON
®
(BIPERIDEN HYDROCHLORIDE 2 MG TABLETS)
NAME OF THE MEDICINE
Non-proprietary name: biperiden hydrochloride
Structural formula (biperiden):
Chemical name (biperiden): α-5-norbornen-2-yl-α-phenyl-1-piperidine
propanol
Molecular weight: 311.5 (biperiden); 347.9 (biperiden hydrochloride)
CAS number: 514-65-8 (biperiden); 1235-82-1 (biperiden hydrochloride)
DESCRIPTION
Biperiden is a white, crystalline, odourless powder, slightly soluble
in water and
alcohol. It is stable in air at ambient temperatures.
Biperiden hydrochloride tablet 2 mg is equivalent to 1.8 mg biperiden.
Biperiden tablets
contain the following excipients: maize starch, calcium hydrogen
phosphate dihydrate,
microcrystalline cellulose, povidone, lactose monohydrate, purified
talc, magnesium
stearate, purified water and pregelatinised potato starch.
INDICATIONS
Akineton is indicated for the treatment of Parkinsonism, drug-induced
extrapyramidal
symptoms, pyramidal spasticity, closed craniocerebral trauma and
post-concussion
symptoms, trigeminal neuralgia and nocturnal cramps.
CONTRAINDICATIONS
Known hypersensitivity to biperiden hydrochloride or to any of the
components in the
medication, narrow angle glaucoma, mechanical stenosis of the
gastrointestinal tract,
in megacolon and in ileus.
PRECAUTIONS
Akineton should be administered with caution to patients with
prostatic hypertrophy
with accumulation of residual urine.
Page 2 of 6
In a few cases, especially in patients with prostatic adenoma,
Akineton may cause
disturbances of micturition calling for a reduction of the dose,
rarely anuria (antidote:
carbachol).
Akineton should be administered with caution in conditions which may
be associated
with
significant
tachycardia
or
in
patients
who
show
an
increased
tendency
to
convulsion.
Particular caution is required treating patients with myasthenia
gravis.
Intraocular pressure should be checked at regular intervals. Caution
should also be
exercised in cases of existing glaucoma.
Impaired memory may arise whilst t